Study Evalutating the Pharmacokinetics (PK) and Safety of a Single Dose of Desvenlafaxine Sustained Release (DVS SR)

Completed · Phase 1

Conditions studied: Depressive Disorder, Major

In brief

To assess the initial pharmacokinetic profile of single doses of 25mg and 50 mg of DVS SR to healthy subjects.

Key facts

Study ID
NCT00440427
Run by
Wyeth is now a wholly owned subsidiary of Pfizer
People needed
12
Starts
2007-02-01
Expected to finish
2007-02-01
Last updated by the study team
2007-12-05

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.